According to Gram Research analysis, a patient with multiple myeloma showed an unusual pattern on a bone imaging scan: calcium deposits accumulated in the stomach lining in addition to the expected high bone activity. This rare finding, documented in a 2026 case report, suggests that myeloma can disrupt calcium regulation throughout the body, not just in bones, potentially causing mineral deposits in unexpected organs.
Researchers documented an unusual case where a cancer patient with multiple myeloma showed abnormal calcium deposits in the stomach, detected through a special imaging scan. This finding is rare because calcium buildup typically occurs in kidneys or bones, not the stomach. The case highlights how serious blood cancers can disrupt the body’s ability to regulate calcium and phosphorus levels, leading to unexpected mineral deposits in organs. Understanding these unusual patterns helps doctors recognize complications in cancer patients and may improve how they monitor and treat these conditions.
Key Statistics
A 2026 case report in Molecular Imaging and Radionuclide Therapy documented a multiple myeloma patient with diffuse calcium deposits in the stomach on a metabolic bone scan, a pattern rarely reported in myeloma imaging.
The case demonstrates that metastatic calcification—abnormal calcium buildup in soft tissues—can occur in the stomach of myeloma patients due to severe disruption of calcium-phosphorus balance caused by cancer cells.
Metabolic superscans in myeloma typically show only increased bone activity with suppressed kidney visualization, making this case’s additional stomach involvement an unusual and clinically significant finding.
The Quick Take
- What they studied: A single patient with multiple myeloma (a type of blood cancer) who showed an unusual pattern on a bone imaging scan, with calcium deposits appearing in the stomach instead of just the bones.
- Who participated: One patient diagnosed with multiple myeloma who underwent a metabolic bone scan (a special imaging test that uses radioactive tracers to show bone activity).
- Key finding: The patient’s scan showed diffuse calcium uptake throughout the skeleton combined with abnormal calcium deposits in the stomach—a rare combination not typically seen in myeloma patients.
- What it means for you: This case report suggests doctors should watch for unexpected calcium deposits in organs beyond bones when treating myeloma patients. However, this is a single case, so it’s not yet clear how common this pattern is or what it means for treatment decisions.
The Research Details
This is a case report, which means doctors documented and described what happened with one specific patient rather than studying a large group. The patient had multiple myeloma, a cancer affecting blood cells that produce antibodies. During routine imaging with a special radioactive tracer (99mTc-MDP), which normally highlights bone activity, the doctors noticed something unusual: the tracer also accumulated in the stomach.
The imaging technique used is called a metabolic superscan. This scan shows how active bones are throughout the body by using a harmless radioactive substance that concentrates where bones are breaking down and rebuilding. In this patient, the scan revealed not only the expected high bone activity but also unexpected calcium deposits in the stomach lining.
The doctors reviewed the patient’s medical history and imaging results to understand why this unusual pattern occurred. They noted that the patient’s calcium and phosphorus levels were disrupted—a common problem in myeloma because cancer cells interfere with how the body regulates these minerals.
Case reports like this one are important because they alert the medical community to unusual presentations of disease. When doctors see a new or unexpected pattern, they can share it with colleagues, which helps everyone recognize similar cases earlier. This particular case matters because it shows that myeloma can cause calcium deposits in unexpected places, not just in bones where doctors typically expect to find them.
As a case report of a single patient, this study provides detailed clinical observation but cannot prove that this pattern is common or that it happens the same way in other patients. The strength of this report is in careful documentation and imaging analysis. The limitation is that one case cannot establish how often this occurs or what it means for patient outcomes. Readers should view this as an interesting clinical observation that warrants further investigation in larger patient groups.
What the Results Show
The patient’s metabolic bone scan showed two main findings: First, there was diffusely increased activity throughout the skeleton, meaning the bones were breaking down and rebuilding at an abnormally high rate—a hallmark of myeloma. Second, and more unusually, the radioactive tracer accumulated in the stomach, indicating calcium deposits in the stomach lining.
This combination is rare because metabolic superscans in myeloma patients typically show only the bone changes. The stomach involvement suggests that the patient’s disrupted calcium-phosphorus balance (caused by the myeloma) led to calcium deposits forming in soft tissues, not just in bones.
The finding reflects what doctors call ‘metastatic calcification’—abnormal calcium buildup in tissues outside the skeleton. This occurs when the body’s ability to regulate calcium and phosphorus is severely disrupted, which happens in myeloma because cancer cells interfere with normal mineral metabolism.
The case demonstrates that myeloma can cause more widespread metabolic disruption than previously documented in this particular imaging pattern. The suppressed kidney visualization on the scan (a normal part of a metabolic superscan) combined with the stomach deposits suggests severe systemic mineral imbalance. This indicates that the patient’s myeloma was affecting calcium regulation throughout the entire body.
Metastatic calcification is known to occur in patients with chronic kidney disease, certain cancers, and vitamin D toxicity. However, the specific pattern of stomach involvement on a metabolic superscan in a myeloma patient appears to be unusual based on available medical literature. Previous reports of myeloma have documented bone involvement and kidney complications, but this particular combination of findings in the stomach is noteworthy and adds to understanding of how myeloma affects mineral metabolism.
This is a single case report, so the findings cannot be generalized to all myeloma patients. We don’t know how common this pattern is, whether it affects patient outcomes, or whether it requires different treatment. The report doesn’t include long-term follow-up information about what happened to this patient afterward. Additionally, case reports cannot establish cause-and-effect relationships—they simply document what was observed in one person.
The Bottom Line
For healthcare providers: Consider that myeloma patients may develop calcium deposits in unexpected locations beyond bones, and metabolic imaging should be interpreted with this possibility in mind. For patients: If you have myeloma, work with your oncology team to monitor calcium and phosphorus levels regularly, as disruptions in these minerals can lead to complications. Confidence level: Low to moderate, based on a single case observation.
Oncologists and radiologists treating myeloma patients should be aware of this unusual presentation. Patients with multiple myeloma and their caregivers should understand that calcium regulation is a potential complication. This case is less relevant for people without myeloma or those with other types of cancer, though similar patterns might occur in other conditions affecting mineral metabolism.
Since this is a single case report, there’s no established timeline for when such complications might develop or how quickly they progress. Calcium and phosphorus imbalances in myeloma can develop over weeks to months, but individual cases vary significantly.
Frequently Asked Questions
Can multiple myeloma cause calcium deposits in the stomach?
Yes, according to a 2026 case report, a myeloma patient developed calcium deposits in the stomach due to severe disruption of calcium-phosphorus balance. This occurs because myeloma interferes with how the body regulates these minerals, potentially causing deposits in unexpected organs beyond bones.
What is a metabolic superscan and why is it used for myeloma patients?
A metabolic superscan is a bone imaging test using radioactive tracers to show where bones are actively breaking down and rebuilding. It helps doctors assess myeloma severity and detect bone damage, since myeloma causes abnormally high bone turnover throughout the skeleton.
What does metastatic calcification mean in cancer patients?
Metastatic calcification is abnormal calcium buildup in soft tissues outside the skeleton, occurring when the body loses its ability to regulate calcium and phosphorus properly. In myeloma, cancer cells disrupt this regulation, potentially causing mineral deposits in organs like the stomach, kidneys, or other tissues.
How common is stomach involvement in multiple myeloma?
Stomach calcium deposits appear to be rare in myeloma based on available medical literature. This 2026 case report documents an unusual presentation, suggesting it’s not a typical complication, though doctors should remain alert for similar patterns in other patients.
Should myeloma patients get special monitoring for calcium levels?
Yes, myeloma patients should have regular blood tests monitoring calcium and phosphorus levels, as disruptions are common and can lead to complications. Early detection through routine lab work helps doctors intervene before serious mineral imbalances develop.
Want to Apply This Research?
- Users with myeloma should track their calcium and phosphorus lab values monthly, recording the specific numbers and dates. This creates a trend line that can help identify when mineral metabolism becomes disrupted.
- Patients should schedule regular lab work to monitor calcium and phosphorus levels as recommended by their oncologist, and report any unusual symptoms (fatigue, bone pain, nausea) that might indicate mineral imbalance.
- Create a dashboard showing calcium and phosphorus trends over time, with alerts if values move outside the normal range. Link imaging scan results to the timeline so patterns can be identified early.
This case report describes a single patient’s unusual presentation and should not be interpreted as establishing how common this complication is or how it should be managed in other patients. Multiple myeloma is a serious condition requiring specialized medical care. If you have myeloma or suspect you might, consult with an oncologist for proper diagnosis and treatment. This article is for educational purposes and does not replace professional medical advice. Always discuss imaging findings and mineral metabolism concerns with your healthcare team.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.